Health Care Reform

AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices

WASHINGTON–(ENEWSPF)–December 15, 2009.  AARP Executive Vice President Nancy LeaMond released this statement following the Senate’s vote against a bipartisan amendment to allow for the safe and legal importation of lower-cost prescription drugs. The amendment, sponsored by Sens. Dorgan, Snowe, McCain, Grassley and Stabenow, was an AARP-designated “Key Vote.”

“AARP is disappointed that the Senate rejected this smart, bipartisan legislation to help bring down prescription drug prices for millions of Americans. For more than 50 years, AARP has been fighting to make health care and prescription drugs more affordable for older Americans. Safe and legal importation is one step toward affordability that we have long supported, and we will continue to work with lawmakers to implement this provision without unnecessary roadblocks.

“Tonight, senators had a choice between meaningful savings for their constituents and higher profits for the drug industry. We’ll be letting our members know where they stood.”

AARP notified the 111th Congress that it was tracking roll call votes on key legislation important to its nearly 40 million members and reporting the outcomes of these votes back to its members and all older Americans at AARP’s Government Watch is a one-stop online portal that will be tracking and publicizing every designated Key Vote on issues facing Americans age 50-plus. A “Key Vote Summary” highlighting votes on these issues will be published at the end of each congressional session.